Skip to main content
. 2022 Mar 28;13:750507. doi: 10.3389/fphar.2022.750507

TABLE 1.

Main classes of cytotoxic antitumoral drugs according to their main mechanism of antiproliferative action.

Class Mechanism of action Cancer type Drugs
Alkylating agents DNA damage by producing inter and intrastrand crosslinks Leukemia, lymphoma, Hodgkin’s disease, multiple myeloma, sarcoma, breast, lung, ovarian cancers Cyclophosphamide
Melphalan
Temozolomide
Platinum drugs
Mitotic inhibitors Alter mitosis due to alterations in the mitotic spindle formation or function Breast, ovarian, lung cancers, myeloma, leukemia, lymphoma Microtubule stabilizers: taxanes
Microtubule destabilizers: vinca alkaloids
Antimetabolites Interfere with the synthesis of DNA or its components Leukemia, breast, ovarian, intestinal cancers 5-fluorouracil
6-mercaptopurine
Cytarabine
Gemcitabine
Methotrexate
Anti-tumor antibiotics Inhibit enzymes that allow DNA to be replicated Many types of cancer Actinomycin-D
Bleomycine
Anthracyclines (daunorubicin, doxorubicin)
Topoisomerase inhibitors Inhibit topoisomerase I or II Leukemia, lung, ovarian, intestinal cancer Topoisomerase I: irinotecan, topotecan
Topoisomerase II: etoposide, teniposide